ReviewBiochemical Society transactions2026
How do low-complexity domain interactions control transcription?
Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A substantial portion of the proteome consists of intrinsically disordered regions (IDRs) that do not fold into well-defined structures. IDRs often comprise low-complexity domains (LCDs), whose repetitive, compositionally biased sequences drive multivalent interactions that can lead to liquid-liquid phase separation, forming biomolecular assemblies. These LCD-mediated assemblies play an important role in transcriptional control, and productive output depends not on their mere presence but on how strongly and selectively LCDs interact. The present review integrates the optimal-interaction, or 'Goldilocks,' principle with RNA polymerase II phosphorylation and RNA-mediated feedback into a unified mechanistic framework spanning the transcription cycle. We connect dysregulation of LCD-mediated multivalent interactions to pathological transcription in cancer, neurodegeneration, and developmental disorders, whether through oncogenic LCD fusions, disease-associated post-translational modifications, or mutations altering phase-separation propensity. We further summarize experimental approaches for studying LCD function, discuss current methodological limitations, and highlight directions for future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.